Company Description

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma.

The company’s product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.

The company is headquartered in Newtown, Pennsylvania.

Helius Medical Technologies, Inc.

Country	United States
Industry	Medical Devices
Sector	Healthcare
Employees	21
CEO	Dane Andreeff

Contact Details

Address: 642 Newtown Yardley Road, Suite 100 Newtown, Pennsylvania 18940 United States
Phone	215 944 6100
Website	heliusmedical.com

Stock Details

Ticker Symbol	HSDT
Exchange	NASDAQ
Share Class	Class A Shares
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001610853
CUSIP Number	42328V884
ISIN Number	US42328V8845
Employer ID	36-4787690
SIC Code	3845

Key Executives

Name	Position
Dane Carl Andreeff	President, Chief Executive Officer and Director
Jeffrey S. Mathiesen CPA	Chief Financial Officer, Treasurer, Secretary and Director
Dr. Antonella Favit-Van Pelt M.D., Ph.D.	Chief Medical Officer
Lawrence Picciano	Senior Vice President of Engineering, Quality and Regulatory Affairs

Latest SEC Filings

Date	Type	Title
Jul 21, 2025	8-K	Current Report
Jul 10, 2025	S-8	Securities to be offered to employees in employee benefit plans
Jul 9, 2025	8-K	Current Report
Jul 7, 2025	8-K	Current Report
Jul 7, 2025	424B5	Filing
Jun 27, 2025	8-K	Current Report
Jun 23, 2025	8-K	Current Report
Jun 20, 2025	8-K	Current Report
Jun 13, 2025	SCHEDULE 13G	Filing
Jun 10, 2025	SCHEDULE 13G	Filing

View All SEC Filings